117 related articles for article (PubMed ID: 38663752)
1. Site-selective antibody-lipid conjugates for surface functionalization of red blood cells and targeted drug delivery.
Li B; Yuan D; Chen H; Wang X; Liang Y; Wong CTT; Xia J
J Control Release; 2024 Jun; 370():302-309. PubMed ID: 38663752
[TBL] [Abstract][Full Text] [Related]
2. Homogeneous antibody-drug conjugates: DAR 2 anti-HER2 obtained by conjugation on isolated light chain followed by mAb assembly.
Farràs M; Miret J; Camps M; Román R; Martínez Ó; Pujol X; Erb S; Ehkirch A; Cianferani S; Casablancas A; Cairó JJ
MAbs; 2020; 12(1):1702262. PubMed ID: 31876436
[TBL] [Abstract][Full Text] [Related]
3. Site-Specific Antibody Labeling by Covalent Photoconjugation of Z Domains Functionalized for Alkyne-Azide Cycloaddition Reactions.
Perols A; Arcos Famme M; Eriksson Karlström A
Chembiochem; 2015 Nov; 16(17):2522-9. PubMed ID: 26417902
[TBL] [Abstract][Full Text] [Related]
4. Development of targeted photodynamic therapy drugs by combining a zinc phthalocyanine sensitizer with TSPO or EGFR binding groups: the impact of the number of targeting agents on biological activity.
Toubia I; Nguyen C; Diring S; Onofre M; Daurat M; Gauthier C; Gary-Bobo M; Kobeissi M; Odobel F
Org Biomol Chem; 2023 Aug; 21(32):6509-6523. PubMed ID: 37341568
[TBL] [Abstract][Full Text] [Related]
5. Site-Selective Lysine Acetylation of Human Immunoglobulin G for Immunoliposomes and Bispecific Antibody Complexes.
Yuan D; Zhang Y; Lim KH; Leung SKP; Yang X; Liang Y; Lau WCY; Chow KT; Xia J
J Am Chem Soc; 2022 Oct; 144(40):18494-18503. PubMed ID: 36167521
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable core-shell nanoassemblies for the delivery of docetaxel and Zn(II)-phthalocyanine inspired by combination therapy for cancer.
Conte C; Ungaro F; Maglio G; Tirino P; Siracusano G; Sciortino MT; Leone N; Palma G; Barbieri A; Arra C; Mazzaglia A; Quaglia F
J Control Release; 2013 Apr; 167(1):40-52. PubMed ID: 23298613
[TBL] [Abstract][Full Text] [Related]
7. An immunoconjugated up-conversion nanocomplex for selective imaging and photodynamic therapy against HER2-positive breast cancer.
Ramírez-García G; Panikar SS; López-Luke T; Piazza V; Honorato-Colin MA; Camacho-Villegas T; Hernández-Gutiérrez R; De la Rosa E
Nanoscale; 2018 May; 10(21):10154-10165. PubMed ID: 29785440
[TBL] [Abstract][Full Text] [Related]
8. Co-administration of zinc phthalocyanine and quercetin via hybrid nanoparticles for augmented photodynamic therapy.
Thakur NS; Mandal N; Patel G; Kirar S; Reddy YN; Kushwah V; Jain S; Kalia YN; Bhaumik J; Banerjee UC
Nanomedicine; 2021 Apr; 33():102368. PubMed ID: 33548477
[TBL] [Abstract][Full Text] [Related]
9. Cancer targeting with biomolecules: a comparative study of photodynamic therapy efficacy using antibody or lectin conjugated phthalocyanine-PEG gold nanoparticles.
Obaid G; Chambrier I; Cook MJ; Russell DA
Photochem Photobiol Sci; 2015 Apr; 14(4):737-47. PubMed ID: 25604735
[TBL] [Abstract][Full Text] [Related]
10. Hybrid Liquid Crystal Nanocarriers for Enhanced Zinc Phthalocyanine-Mediated Photodynamic Therapy.
Nag OK; Naciri J; Erickson JS; Oh E; Delehanty JB
Bioconjug Chem; 2018 Aug; 29(8):2701-2714. PubMed ID: 29990422
[TBL] [Abstract][Full Text] [Related]
11. Near-Infrared Laser-Triggered, Self-Immolative Smart Polymersomes for in vivo Cancer Therapy.
Tang Q; Hu P; Peng H; Zhang N; Zheng Q; He Y
Int J Nanomedicine; 2020; 15():137-149. PubMed ID: 32021170
[TBL] [Abstract][Full Text] [Related]
12. Assembly of High-Potency Photosensitizer-Antibody Conjugates through Application of Dendron Multiplier Technology.
Bryden F; Maruani A; Rodrigues JMM; Cheng MHY; Savoie H; Beeby A; Chudasama V; Boyle RW
Bioconjug Chem; 2018 Jan; 29(1):176-181. PubMed ID: 29216717
[TBL] [Abstract][Full Text] [Related]
13. Enhancing antitumor efficacy of NIR-I region zinc phthalocyanine@upconversion nanoparticle through lysosomal escape and mitochondria targeting.
Ye Q; Wang J; Guo R; Chen G; Shen Y; Wu Y; Wang J; Lin Z; Wang K; Chen J; Peng Y
J Photochem Photobiol B; 2024 Jun; 255():112923. PubMed ID: 38692166
[TBL] [Abstract][Full Text] [Related]
14. Novel pH-sensitive zinc phthalocyanine assembled with albumin for tumor targeting and treatment.
Wang Y; Zheng K; Xuan G; Huang M; Xue J
Int J Nanomedicine; 2018; 13():7681-7695. PubMed ID: 30538452
[TBL] [Abstract][Full Text] [Related]
15. Nanostructured delivery system for zinc phthalocyanine: preparation, characterization, and phototoxicity study against human lung adenocarcinoma A549 cells.
da Volta Soares M; Oliveira MR; dos Santos EP; de Brito Gitirana L; Barbosa GM; Quaresma CH; Ricci-Júnior E
Int J Nanomedicine; 2011; 6():227-38. PubMed ID: 21499420
[TBL] [Abstract][Full Text] [Related]
16. Radiolabeling,
Er O; Tuncel A; Ocakoglu K; Ince M; Kolatan EH; Yilmaz O; Aktaş S; Yurt F
Mol Pharm; 2020 Jul; 17(7):2648-2659. PubMed ID: 32412765
[TBL] [Abstract][Full Text] [Related]
17. Development and in vitro proof-of-concept of interstitially targeted zinc- phthalocyanine liposomes for photodynamic therapy.
Broekgaarden M; de Kroon AI; Gulik TM; Heger M
Curr Med Chem; 2014; 21(3):377-91. PubMed ID: 23931271
[TBL] [Abstract][Full Text] [Related]
18. Dual-Sensitive PEG-Sheddable Nanodrug Hierarchically Incorporating PD-L1 Antibody and Zinc Phthalocyanine for Improved Immuno-Photodynamic Therapy.
Su Z; Xiao Z; Huang J; Wang Y; An Y; Xiao H; Peng Y; Pang P; Han S; Zhu K; Shuai X
ACS Appl Mater Interfaces; 2021 Mar; 13(11):12845-12856. PubMed ID: 33709684
[TBL] [Abstract][Full Text] [Related]
19. Site-Specifically Labeled Antibody-Drug Conjugate for Simultaneous Therapy and ImmunoPET.
Adumeau P; Vivier D; Sharma SK; Wang J; Zhang T; Chen A; Agnew BJ; Zeglis BM
Mol Pharm; 2018 Mar; 15(3):892-898. PubMed ID: 29356543
[TBL] [Abstract][Full Text] [Related]
20. Improving the topical delivery of zinc phthalocyanine using oleic acid as a penetration enhancer: in vitro permeation and retention.
da Silva ER; de Freitas ZM; Gitirana Lde B; Ricci-Júnior E
Drug Dev Ind Pharm; 2011 May; 37(5):569-75. PubMed ID: 21128702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]